CASE STUDIES COVID-19

Reference information/links/test results

3’065 articles featuring Ozone Therapy published since 1945 to date details

Handbook of COVID-19 Prevention and Treatment

Prof. Tingbo LIANG Editor-in-Chief of the Chairman of The First Affiliated Hospital, Zhejiang University School of Medicine

The Jack Ma Foundation and Alibaba Foundation have convened a group of medical experts who have just returned from the frontlines of fighting the pandemic. With the support of The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), they quickly published a guidebook on the clinical experience of how to treat this new coronavirus. The treatment guide offers advice and reference against the pandemic for medical staff around the world who are about to join the war

A Notice Concerning the Establishment of a Scientific Research Group on the use of Trioxide (O3) Treatment for Coronavirus (COVID-19) Pneumonia at the People’s Hospital of Guangshan County

In order to enhance the prevention, control and treatment of the coronavirus (COVID-19) pneumonia as well as strengthen our hospital’s scientific research on the said disease, a meeting convened by the Dean’s Office has decided to establish a scientific research group on the use of trioxide (O3) treatment for the novel coronavirus pneumonia at the People’s Hospital of Guangshan County. The names of which are as follows:

Publication in the Chinese media about the treatment with ozone-oxygen in China, in the government hospital in Guangshan

The treatment guide offers advice and reference against the pandemic for medical staff around the world who are about to join the war.

In the department of anaesthesia and resuscitation in collaboration with infectivology, out of 36 patients treated like this, only 1 needed to be intubated, the others were discharged

First report on the use of SIOOT ozone oxygen in patients hospitalised with Covid-19 

Ozone therapy treatment – It is considered suitable the treatment could be carried out under the responsibility of the doctor, after acquiring the patient’s informed consent – highlighted text from a letter sent out from the Ministry for Health Rome

Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures

1 Marianno Franzini,

2 Luigi Valdenassi

3 Giovanni Ricevuti

SIOOT International, Comunian Clinic, Gorle (BG), High School in Oxygen Ozone Therapy, University of Pavia;

SIOOT, Italian Society of Oxygen Ozone Therapy, High School in Oxygen Ozone Therapy, University of Pavia, Italy

3 Department of Drug Science, University of Pavia, Italy, High School in Oxygen Ozone Therapy, University of Pavia;

Covid-19 treatment study results Italy

Recent results show that O2-O3 treatment would be a promising therapy for COVID-19 patients. It leads patients to a fast recovery from ARDS via the improvement of major respiratory indexes and blood gas parameters, following a relatively short time of dispensed forced ventilation (about one to two weeks).

This study may encourage the scientific community to further investigate and evaluate the proposed method for the treatment of COVID-19 patients.

No new Covid-19 deaths in the Balearic Islands as Ibiza clinic becomes first in Spain to use pioneering ozone therapy 

Potential use of ozone in SARS-CoV-2 / COVID-19.
Official Expert Opinion of the International Scientific Committee of Ozone Therapy (ISCO3). ISCO3/EPI/00/04 (March 14, 2020). Approved by ISCO3 on 13/03/2020.

Follow-up by country to the preliminary results about the use of systemic of O2/O3 in the treatment of Novel Coronavirus Pneumonia (COVID-19)

ABOUT US

One of the leading suppliers of colon hydrotherapy and medical ozone therapy equipment, supplies, training, and support.
dotolo europe company logo

SECURE ONLINE PAYMENT

 

paypal secured payments logo
sagepay secured payments logo

TALK TO US

Tel: +44 (0)844 854 92 22

Monday to Friday 8:30 – 6:30

Dotolo Europe Ltd.
Unit 5 Base 329 Headley Road East, Woodley, Reading, Berkshire RG5 4AZ

VAT number: 103 8046 49

© 2018 Dotolo Europe Ltd. All rights reserved.